Beranda › Histiositosis Sel Langerhans › California
Uji klinis Histiositosis Sel Langerhans di California
3 studi untuk Histiositosis Sel Langerhans mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- dan 6 lainnya
Menerima pesertaFase 2
180 Days – 22 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05828069Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Hospital of Orange County, Orange
- UCSF Benioff Children's Hospital, San Francisco
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Stanford Children's Hospital, Lucile Packard Children's Hospital, Palo Alto
- Rady Children's Hospital - San Diego, San Diego
Menerima pesertaFase 3
Hingga usia 21 · Semua jenis kelamin · Diperbarui 11 Sep 2025 · NCT02670707Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.